<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00607867</url>
  </required_header>
  <id_info>
    <org_study_id>CLIN-010-07F</org_study_id>
    <nct_id>NCT00607867</nct_id>
  </id_info>
  <brief_title>LoBAG30 Diet in Patients on Metformin</brief_title>
  <acronym>LoBAG Diet</acronym>
  <official_title>Metabolic Response to a LoBAG30 Diet in Diabetic Patients on Metformin</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>VA Office of Research and Development</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>VA Office of Research and Development</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      We will determine the metabolic response to a Low Biologically Available Glucose Diet
      (LoBAG30) in subjects currently receiving the maximum dose of metformin as monotherapy in
      whom the glycohemoglobin is not at an acceptable level (&gt;8.0%). Our hypothesis is that
      introduction of a LoBAG30 diet to subjects currently treated with a full therapeutic dose of
      metformin will improve blood glucose control in people who have not achieved an acceptable
      total glycohemoglobin on metformin alone.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Subjects will ingest a control diet (55% carbohydrate (CHO), 15% protein, 30% fat) or a
      LoBAG30 diet (30% CHO, 30% protein, 40% fat) in a parallel design with block randomization in
      pairs of two. Subjects will return to the study center twice each week while on the diets to
      have blood glucose, glycohemoglobin, lactate, weight and blood pressure measured, and to have
      urine assayed for urea and creatinine. At the beginning and end of the 5 week study period,
      the subjects will be admitted to the study center for 28 hours during which time blood will
      be drawn for 24 hour profiles of glucose, insulin, other hormones and several metabolites.
      For those subjects randomized to the LoBAG30 arm of the study, the control diet will be given
      during the first 24 hour study period; the assigned diet will be given at the end of the 5
      week period.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    The funding ended before the study was completed.
  </why_stopped>
  <start_date>April 2008</start_date>
  <completion_date type="Actual">March 2011</completion_date>
  <primary_completion_date type="Actual">January 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in %Hemoglobin A1c at 5 Weeks From Baseline</measure>
    <time_frame>Baseline and 5 weeks after dietary intervention</time_frame>
    <description>Hemoglobin A1c measured before and after 5 weeks on the diet</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Total Glucose Area at 5 Weeks From Baseline</measure>
    <time_frame>Baseline and 5 weeks after dietary intervention</time_frame>
    <description>The area response is measured using zero as baseline. The area is measured before dietary intervention, and following 5 weeks of dietary intervention.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Body Weight at 5 Weeks From Baseline</measure>
    <time_frame>baseline and 5 weeks after dietary intervention</time_frame>
    <description>Subjects were to remain weight stable. We expected less than 2 pound weight change over 5 weeks. Weight was measured before dietary intervention, and after 5 weeks of dietary intervention.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Overnight Fasting Glucose Concentration at 5 Weeks From Baseline</measure>
    <time_frame>baseline and 5 weeks after dietary intervention</time_frame>
    <description>Overnight fasting glucose concentration was measured before dietary intervention and after 5 weeks of dietary intervention.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Microalbumin Excretion</measure>
    <time_frame>baseline and 5 weeks after dietary intervention</time_frame>
    <description>change in urinary albumin excretion was measured before dietary intervention and after 5 weeks of dietary intervention</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Fasting Triglycerides at 5 Weeks From Baseline</measure>
    <time_frame>baseline and 5 weeks after dietary intervention</time_frame>
    <description>Overnight fasting triglycerides concentration was measured before dietary intervention and after 5 weeks of dietary intervention</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Diabetes Mellitus</condition>
  <condition>Diet</condition>
  <arm_group>
    <arm_group_label>Arm 1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>A LoBAG30, weight maintenance diet will be given to subjects on metformin. All food will be provided for 5 weeks.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm 2</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>A weight maintenance, control diet consisting of 55% carbohydrate, 15% protein, 30% fat will be given to subjects on metformin. All food will be provided for 5 weeks.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>LoBAG30 diet</intervention_name>
    <description>A LoBAG30 diet consists of 30% of total energy intake as carbohydrate, 30% protein, and 40% fat.</description>
    <arm_group_label>Arm 1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Control Diet</intervention_name>
    <description>A control diet consists of 55% of total energy intake as carbohydrate, 15% protein, 30% fat</description>
    <arm_group_label>Arm 2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  People with type 2 diabetes mellitus who currently are receiving the maximal dose of
             metformin monotherapy (2500 mg/day).

          -  These subjects will have had a stable glycohemoglobin (tGHb) in an unacceptably high
             range (8-11%) for at least 4 months prior to beginning the study.

          -  Subjects with tGHB &gt; 11% (HbA1c &gt; 10%) will not be recruited into the study.

        Exclusion Criteria:

          -  Hematological abnormalities

          -  liver disease

          -  kidney disease

          -  macroalbuminuria (&gt;300 mg albumin/24 hours)

          -  untreated thyroid disease

          -  congestive heart failure

          -  angina

          -  life-threatening malignancies

          -  proliferative retinopathy

          -  severe diabetic neuropathy

          -  peripheral vascular disease

          -  serious psychological disorders

          -  a body mass index &gt; 35

          -  and a fasting triglyceride of &gt;400 mg/dl.

               -  Subjects taking slow-release metformin will not be studied.

               -  Subjects taking medications other than metformin, known to affect fuel metabolism
                  such as:

          -  insulin

          -  the sulfonylureas

          -  glucagon-like peptide 1 (GLP-1) analogs and metabolic inhibitors

          -  pramlintide

          -  prednisone and similar steroids

          -  thyroid hormone

          -  antipsychotic medications

          -  thiazide diuretics

          -  medroxyprogesterone

          -  high dose aspirin, also will be excluded.

               -  If concentrations of serum folate, B12 or iron are low, the subject will be
                  excluded from the study until corrected, i.e. until normal concentrations are
                  recorded.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mary Gannon, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Minneapolis Veterans Affairs Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>VA Medical Center, Minneapolis</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55417</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 31, 2008</study_first_submitted>
  <study_first_submitted_qc>February 5, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 6, 2008</study_first_posted>
  <results_first_submitted>November 17, 2014</results_first_submitted>
  <results_first_submitted_qc>December 10, 2014</results_first_submitted_qc>
  <results_first_posted type="Estimate">December 12, 2014</results_first_posted>
  <last_update_submitted>December 10, 2014</last_update_submitted>
  <last_update_submitted_qc>December 10, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 12, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Diabetes Mellitus (type 2)</keyword>
  <keyword>Diet</keyword>
  <keyword>Glycohemoglobin</keyword>
  <keyword>Lipids</keyword>
  <keyword>Kidney Function</keyword>
  <keyword>Glycemic Index</keyword>
  <keyword>Dietary Protein</keyword>
  <keyword>Dietary Carbohydrate</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Metformin</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <pre_assignment_details>Proposed study design was 20 subjects, 10/arm. (Parallel arm design requested by grant Reviewers.) At the end of the funding period, 14 subjects had been enrolled and studied, 7 in each arm.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>LoBAG30 Diet</title>
          <description>A LoBAG30, weight maintenance diet 30% CHO, 30% Pro, 50% fat</description>
        </group>
        <group group_id="P2">
          <title>Control Diet</title>
          <description>A weight maintenance, control diet 55% CHO, 15% protein, 30% fat</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="7"/>
                <participants group_id="P2" count="7"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="7"/>
                <participants group_id="P2" count="7"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Subjects with type 2 diabetes being treated with metformin</population>
      <group_list>
        <group group_id="B1">
          <title>LoBAG30 Diet</title>
          <description>A LoBAG30, weight maintenance diet 30% carbohydrate, 30% protein, and 40% fat.</description>
        </group>
        <group group_id="B2">
          <title>Control Diet</title>
          <description>A weight maintenance, control diet consisting 55% carbohydrate, 15% protein, 30% fat</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="7"/>
            <count group_id="B2" value="7"/>
            <count group_id="B3" value="14"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="62" lower_limit="51" upper_limit="71"/>
                    <measurement group_id="B2" value="61" lower_limit="53" upper_limit="66"/>
                    <measurement group_id="B3" value="61.6" lower_limit="51" upper_limit="71"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Change in %Hemoglobin A1c at 5 Weeks From Baseline</title>
        <description>Hemoglobin A1c measured before and after 5 weeks on the diet</description>
        <time_frame>Baseline and 5 weeks after dietary intervention</time_frame>
        <group_list>
          <group group_id="O1">
            <title>LoBAG30 Diet</title>
            <description>A LoBAG30, weight maintenance diet 30% CHO, 30% Pro, 50% fat</description>
          </group>
          <group group_id="O2">
            <title>Control Diet</title>
            <description>A weight maintenance, control diet 55% CHO, 15% protein, 30% fat</description>
          </group>
        </group_list>
        <measure>
          <title>Change in %Hemoglobin A1c at 5 Weeks From Baseline</title>
          <description>Hemoglobin A1c measured before and after 5 weeks on the diet</description>
          <units>Change in % A1c at 5 weeks from baseli</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="7"/>
                <count group_id="O2" value="7"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.9" spread="0.23"/>
                    <measurement group_id="O2" value="-0.9" spread="0.16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Microalbumin Excretion</title>
        <description>change in urinary albumin excretion was measured before dietary intervention and after 5 weeks of dietary intervention</description>
        <time_frame>baseline and 5 weeks after dietary intervention</time_frame>
        <group_list>
          <group group_id="O1">
            <title>LoBAG30 Diet</title>
            <description>A LoBAG30, weight maintenance diet 30% CHO, 30% Pro, 50% fat</description>
          </group>
          <group group_id="O2">
            <title>Control Diet</title>
            <description>A weight maintenance, control diet 55% CHO, 15% protein, 30% fat</description>
          </group>
        </group_list>
        <measure>
          <title>Microalbumin Excretion</title>
          <description>change in urinary albumin excretion was measured before dietary intervention and after 5 weeks of dietary intervention</description>
          <units>mg/day</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="7"/>
                <count group_id="O2" value="7"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.9" spread="4.2"/>
                    <measurement group_id="O2" value="-8.3" spread="3.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change in Total Glucose Area at 5 Weeks From Baseline</title>
        <description>The area response is measured using zero as baseline. The area is measured before dietary intervention, and following 5 weeks of dietary intervention.</description>
        <time_frame>Baseline and 5 weeks after dietary intervention</time_frame>
        <group_list>
          <group group_id="O1">
            <title>LoBAG30 Diet</title>
            <description>A LoBAG30, weight maintenance diet 30% CHO, 30% Pro, 50% fat</description>
          </group>
          <group group_id="O2">
            <title>Control Diet</title>
            <description>A weight maintenance, control diet 55% CHO, 15% protein, 30% fat</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Total Glucose Area at 5 Weeks From Baseline</title>
          <description>The area response is measured using zero as baseline. The area is measured before dietary intervention, and following 5 weeks of dietary intervention.</description>
          <units>mg hr/dl</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="7"/>
                <count group_id="O2" value="7"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-957" spread="302"/>
                    <measurement group_id="O2" value="-691" spread="84"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change in Body Weight at 5 Weeks From Baseline</title>
        <description>Subjects were to remain weight stable. We expected less than 2 pound weight change over 5 weeks. Weight was measured before dietary intervention, and after 5 weeks of dietary intervention.</description>
        <time_frame>baseline and 5 weeks after dietary intervention</time_frame>
        <group_list>
          <group group_id="O1">
            <title>LoBAG30 Diet</title>
            <description>A LoBAG30, weight maintenance diet 30% CHO, 30% Pro, 50% fat</description>
          </group>
          <group group_id="O2">
            <title>Control Diet</title>
            <description>A weight maintenance, control diet 55% CHO, 15% protein, 30% fat</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Body Weight at 5 Weeks From Baseline</title>
          <description>Subjects were to remain weight stable. We expected less than 2 pound weight change over 5 weeks. Weight was measured before dietary intervention, and after 5 weeks of dietary intervention.</description>
          <units>pounds</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="7"/>
                <count group_id="O2" value="7"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.7" spread="0.7"/>
                    <measurement group_id="O2" value="-2.6" spread="1.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change in Overnight Fasting Glucose Concentration at 5 Weeks From Baseline</title>
        <description>Overnight fasting glucose concentration was measured before dietary intervention and after 5 weeks of dietary intervention.</description>
        <time_frame>baseline and 5 weeks after dietary intervention</time_frame>
        <group_list>
          <group group_id="O1">
            <title>LoBAG30 Diet</title>
            <description>A LoBAG30, weight maintenance diet 30% CHO, 30% Pro, 50% fat</description>
          </group>
          <group group_id="O2">
            <title>Control Diet</title>
            <description>A weight maintenance, control diet 55% CHO, 15% protein, 30% fat</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Overnight Fasting Glucose Concentration at 5 Weeks From Baseline</title>
          <description>Overnight fasting glucose concentration was measured before dietary intervention and after 5 weeks of dietary intervention.</description>
          <units>mg/dl</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="7"/>
                <count group_id="O2" value="7"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-22" spread="16.5"/>
                    <measurement group_id="O2" value="-33" spread="4.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Fasting Triglycerides at 5 Weeks From Baseline</title>
        <description>Overnight fasting triglycerides concentration was measured before dietary intervention and after 5 weeks of dietary intervention</description>
        <time_frame>baseline and 5 weeks after dietary intervention</time_frame>
        <group_list>
          <group group_id="O1">
            <title>LoBAG30 Diet</title>
            <description>A LoBAG30, weight maintenance diet 30% CHO, 30% Pro, 50% fat</description>
          </group>
          <group group_id="O2">
            <title>Control Diet</title>
            <description>A weight maintenance, control diet 55% CHO, 15% protein, 30% fat</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Fasting Triglycerides at 5 Weeks From Baseline</title>
          <description>Overnight fasting triglycerides concentration was measured before dietary intervention and after 5 weeks of dietary intervention</description>
          <units>mg/dl</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="7"/>
                <count group_id="O2" value="7"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-18" spread="12.9"/>
                    <measurement group_id="O2" value="-24" spread="9.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>LoBAG30 Diet</title>
          <description>A LoBAG30, weight maintenance diet will be given to subjects on metformin. All food will be provided for 5 weeks.
LoBAG30 diet: A LoBAG30 diet consists of 30% of total energy intake as carbohydrate, 30% protein, and 40% fat.</description>
        </group>
        <group group_id="E2">
          <title>Control Diet</title>
          <description>A weight maintenance, control diet consisting of 55% carbohydrate, 15% protein, 30% fat will be given to subjects on metformin. All food will be provided for 5 weeks.
Control Diet: A control diet consists of 55% of total energy intake as carbohydrate, 15% protein, 30% fat</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>Funding ended with only 14 subjects studied. With a parallel arm design, we were not able to draw any conclusions from the study. Funds were unavailable for a more sophisticated statistical analysis.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Mary C. Gannon, Ph.D.</name_or_title>
      <organization>Minneapolis VA Health Care System, Metabolic Research Labortory</organization>
      <phone>6124672895</phone>
      <email>ganno004@umn.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

